Data from the Hong Kong Stock Exchange reveals that on July 23, Fullgoal Fund increased its holdings in BIOCYTOGEN-B (02315) by 250,000 shares, with each share priced at approximately HK$53.9468. The total transaction value was around HK$13.4867 million.
Following the purchase, the fund's latest share count stands at approximately 7.8565 million shares, representing a 7.09% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments